Objectives To provide laboratory support for this CIPRA program To provide central laboratory facilities at HIV-NAT for those sites with limited capacity To develop laboratory capacity in regional sites where possible To develop QA/QC programs to monitor inter- and intra-laboratory variability and to standardize laboratory procedures for specialized study endpoint assays To provide regional training program in principles of pharmaceutical level Good Laboratory Practice, laboratory techniques and quality management Specific aims To employ additional technical personnel in accordance with increased activity according to the projects To purchase additional laboratory equipment to accommodate the increased activity associated with the projects To procure additional administrative infrastructure to support this laboratory core To expand the existing laboratory facilities to accommodate additional activity associated with the CIPRA program Methods Two full-time laboratory technologists and three assistant laboratory technicians will be employed. This number is based on the current formula for workload distribution for employment at the HIV-NAT laboratory. A laboratory administrative assistant will be employed to oversee the clerical aspects of the four projects. As HIV-NAT will be the central laboratory for many sites, the centrifuge, biological safety cabinet and flow cytometer are needed with the expected increase in activity. Other existing equipment is adequate. Additional -80 deg freezers will be needed for-long term specimen storage for all four projects. It is envisaged that most long-term storage will occur at HIV-NAT. A system of specimen transport between the sites and HIV-NAT using ground and air transport with portable liquid nitrogen tanks will be developed due to the unreliable supply of solid carbon dioxide (dry ice) in remote sites. There will be a need for temporary local storage at regional sites prior to shipment. Small freezers for temporary specimen storage will be purchased for this purpose.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
4U19AI053741-06
Application #
7900791
Study Section
Special Emphasis Panel (ZAI1-EC-A (S4))
Project Start
2009-06-01
Project End
2011-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
6
Fiscal Year
2009
Total Cost
$89,619
Indirect Cost
Name
HIV-Nat, the Thai Red Cross AIDS Rch Center
Department
Type
DUNS #
671556129
City
Bangkok
State
Country
Thailand
Zip Code
10330
Paul, Robert; Apornpong, Tanakorn; Prasitsuebsai, Wasana et al. (2018) Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV. J Acquir Immune Defic Syndr 77:417-426
Paul, Robert; Prasitsuebsai, Wasana; Jahanshad, Neda et al. (2018) Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV. Pediatr Infect Dis J 37:662-668
Bunupuradah, Torsak; Hansudewechakul, Rawiwan; Kosalaraksa, Pope et al. (2015) HLA-DRB1454 and predictors of new-onset asthma in HIV-infected Thai children. Clin Immunol 157:26-9
Ananworanich, Jintanat; Kerr, Stephen J; Jaimulwong, Tanyathip et al. (2015) Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children. J Virus Erad 1:196-202
Kerr, Stephen J; Puthanakit, Thanyawee; Vibol, Ung et al. (2014) Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care 26:1327-35
Intasan, Jintana; Bunupuradah, Torsak; Vonthanak, Saphonn et al. (2014) Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDS 28:296-302
Puthanakit, Thanyawee; Ananworanich, Jintanat; Vonthanak, Saphonn et al. (2013) Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J 32:501-8
Bunupuradah, Torsak; Kosalaraksa, Pope; Vibol, Ung et al. (2013) Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study. AIDS Patient Care STDS 27:596-603
Puthanakit, Thanyawee; Saphonn, Vonthanak; Ananworanich, Jintanat et al. (2012) Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis 12:933-41
Haas, David W; Mootsikapun, Piroon; Ruxrungtham, Kiat et al. (2012) Clinical perspectives on human genetic screening to prevent nevirapine toxicity. Per Med 9:773-782

Showing the most recent 10 out of 16 publications